Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84


Characterization of an HIV-1 group M variant that is distinct from the known subtypes.

van der Hoek L, Pollakis G, Lukashov VV, Jebbink MF, Jeeninga RE, Bakker M, Dukers N, Jurriaans S, Paxton WA, Back NK, Berkhout B.

AIDS Res Hum Retroviruses. 2007 Mar;23(3):466-70.


The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa.

Novitsky V, Wester CW, DeGruttola V, Bussmann H, Gaseitsiwe S, Thomas A, Moyo S, Musonda R, Van Widenfelt E, Marlink RG, Essex M.

AIDS Res Hum Retroviruses. 2007 Jul;23(7):868-78.


An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I).

Gao F, Robertson DL, Carruthers CD, Li Y, Bailes E, Kostrikis LG, Salminen MO, Bibollet-Ruche F, Peeters M, Ho DD, Shaw GM, Sharp PM, Hahn BH.

J Virol. 1998 Dec;72(12):10234-41.


A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants.

Jameel S, Zafrullah M, Ahmad M, Kapoor GS, Sehgal S.

AIDS. 1995 Jul;9(7):685-90.


Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.

van der Hoek L, Back N, Jebbink MF, de Ronde A, Bakker M, Jurriaans S, Reiss P, Parkin N, Berkhout B.

J Virol. 2005 Mar;79(6):3536-43.


Predictive factors and selection of thymidine analogue mutations by nucleoside reverse transcriptase inhibitors according to initial regimen received.

Flandre P, Descamps D, Joly V, Meiffrédy V, Tamalet C, Izopet J, Aboulker JP, Brun-Vézinet F.

Antivir Ther. 2003 Feb;8(1):65-72.


The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.

Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, Fultz PN, Girard M, Shaw GM, Hahn BH, Sharp PM.

J Virol. 1996 Oct;70(10):7013-29.


Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolates.

Lafeuillade A, Poggi C, Hittinger G, Chadapaud S.

HIV Med. 2001 Oct;2(4):231-5.


Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance.

Loemba H, Brenner B, Parniak MA, Ma'ayan S, Spira B, Moisi D, Oliveira M, Detorio M, Essex M, Wainberg MA.

Antiviral Res. 2002 Nov;56(2):129-42.


[Cloning and characterization of a full-length HIV-1 genome of a prevalent subtype B-Thai strain in Henan Province].

Feng FM, Bao ZY, Zhuang DM, Liu SY, Li L, Li JY.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Dec;18(4):356-9. Chinese.


Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons.

Garcia-Lerma JG, Nidtha S, Blumoff K, Weinstock H, Heneine W.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13907-12. Epub 2001 Nov 6.


CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J.

Montavon C, Toure-Kane C, Nkengasong JN, Vergne L, Hertogs K, Mboup S, Delaporte E, Peeters M.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):522-30.


Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.

Lukashov VV, Cornelissen MT, Goudsmit J, Papuashvilli MN, Rytik PG, Khaitov RM, Karamov EV, de Wolf F.

AIDS. 1995 May;9(5):435-9.


A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Gao F, Robertson DL, Carruthers CD, Morrison SG, Jian B, Chen Y, Barré-Sinoussi F, Girard M, Srinivasan A, Abimiku AG, Shaw GM, Sharp PM, Hahn BH.

J Virol. 1998 Jul;72(7):5680-98.


An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa.

van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C.

AIDS. 1997 Jan;11(1):81-7.


Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Gao F, Morrison SG, Robertson DL, Thornton CL, Craig S, Karlsson G, Sodroski J, Morgado M, Galvao-Castro B, von Briesen H, Beddows S, Weber J, Sharp PM, Shaw GM, Hahn BH.

J Virol. 1996 Mar;70(3):1651-67.


Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso.

Sylla M, Chamberland A, Boileau C, Traoré HA, Ag-Aboubacrine S, Cissé M, Koala S, Drabo J, Diallo I, Niamba P, Tremblay-Sher D, Machouf N, Rashed S, Nickle DC, Nguyen VK, Tremblay CL; ATARAO Group.

Antivir Ther. 2008;13(1):141-8.


Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates.

Hunt GM, Papathanasopoulos MA, Gray GE, Tiemessen CT.

Virus Genes. 2003 Jan;26(1):49-56.

Items per page

Supplemental Content

Write to the Help Desk